HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federica Miglietta Selected Research

Messenger RNA (mRNA)

1/2023HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
11/2022HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Federica Miglietta Research Topics

Disease

29Breast Neoplasms (Breast Cancer)
04/2024 - 05/2016
12Neoplasms (Cancer)
04/2024 - 01/2017
5Neoplasm Metastasis (Metastasis)
09/2023 - 01/2017
5Triple Negative Breast Neoplasms
01/2023 - 01/2019
4Pathologic Complete Response
01/2023 - 01/2021
3Brain Neoplasms (Brain Tumor)
09/2023 - 01/2017
2Residual Neoplasm
01/2023 - 01/2020
1Margins of Excision
10/2020
1Alopecia (Baldness)
01/2020
1Genomic Instability
09/2019
1Hypercholesterolemia
09/2010

Drug/Important Bio-Agent (IBA)

14Hormones (Hormone)IBA
12/2023 - 05/2016
6Biomarkers (Surrogate Marker)IBA
07/2021 - 09/2019
5Phenobarbital (Luminal)FDA Link
12/2023 - 02/2021
5Trastuzumab (Herceptin)FDA Link
11/2023 - 01/2018
4AnthracyclinesIBA
01/2023 - 01/2020
3ErbB Receptors (EGF Receptor)IBA
11/2023 - 11/2020
2Messenger RNA (mRNA)IBA
01/2023 - 11/2022
2Carboplatin (JM8)FDA LinkGeneric
01/2023 - 01/2023
2Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2023
2Immunoconjugates (Immunoconjugate)IBA
01/2023 - 10/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2022 - 04/2020
2taxaneIBA
11/2020 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2020 - 11/2019
1N-acetyltalosaminuronic acid (NAT)IBA
01/2023
1trastuzumab deruxtecanIBA
01/2023
1Ado-Trastuzumab EmtansineIBA
01/2023
1Letrozole (Femara)FDA LinkGeneric
11/2022
1pertuzumabIBA
11/2022
1Lapatinib (GW572016)FDA Link
01/2021
1Epidermal Growth Factor (EGF)IBA
08/2020
1olaparibIBA
04/2020
1LigandsIBA
11/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2019
1TensinsIBA
09/2019
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2019
1Androgen Receptors (Androgen Receptor)IBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
06/2018
1Estrogen ReceptorsIBA
06/2018
1LDL CholesterolIBA
09/2010

Therapy/Procedure

12Neoadjuvant Therapy
06/2023 - 01/2020
8Therapeutics
04/2024 - 01/2017
7Drug Therapy (Chemotherapy)
11/2023 - 01/2020
3Immunotherapy
01/2021 - 11/2019
1Adjuvant Chemotherapy
04/2024
1Mastectomy (Mammectomy)
10/2020
1Radiotherapy
01/2017
1Combined Modality Therapy
01/2017
1Ambulatory Care (Outpatient Care)
09/2010